Secondary analyses from a randomized clinical trial: Age as the key prognostic factor in endometrial carcinoma

American Journal of Obstetrics and Gynecology

Volumn 210, Issue 4, 2014, Pages 363.e1-363.e10

  Benedetti Panici, Pierluigi ^a   Basile, Stefano ^d   Salerno, Maria Giovanna ^d   Di Donato, Violante ^a   Marchetti, Claudia ^a   Perniola, Giorgia ^a   Palagiano, Antonio ^a   Perutelli, Alessandra ^d   Maneschi, Francesco ^e   Lissoni, Andrea Alberto ^f   Signorelli, Mauro ^f   Scambia, Giovanni ^b   Tateo, Saverio ^g   Mangili, Giorgia ^h   Katsaros, Dionyssios ^k   Campagnutta, Elio ^l   Donadello, Nicoletta ^m   Greggi, Stefano ⁿ   Melpignano, Mauro ^o   Raspagliesi, Francesco ⁱ   Cormio, Gennaro ^p   Grassi, Roberto ^q   Franchi, Massimo ^r   Giannarelli, Diana ^c   Fossati, Roldano ^j   Torri, Valter ^j   Crocè, Clara ^s   Mangioni, Costantino ^f   more..

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY HOSPITAL OF PISA   (Italy)

^e SANTA MARIA GORETTI HOSPITAL   (Italy)

^f SAN GERARDO HOSPITAL   (Italy)

^g FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^h SAN RAFFAELE HOSPITAL   (Italy)

ⁱ NATIONAL CANCER INSTITUTE   (Italy)

^j MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^k S ANNA HOSPITAL   (Italy)

^l Aviano AB Hospital   (Italy)

^m University of Varese   (Italy)

ⁿ NATIONAL CANCER INSTITUTE   (Italy)

^o UNIVERSITY HOSPITAL OF PARMA   (Italy)

^p UNIVERSITY OF BARI   (Italy)

^q TREVIGLIO HOSPITAL   (Italy)

^r UNIVERSITY OF VERONA   (Italy)

^s Department of Obstetrics and Gynecology Northeast Women's Health and Obstetrics   (United States)

more..

Author keywords

age; body mass index; endometrial carcinoma; prognostic factors

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER GRADING; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS;

AGE; BODY MASS INDEX; ENDOMETRIAL CARCINOMA; PROGNOSTIC FACTORS;

AGE FACTORS; AGED; BODY MASS INDEX; CARCINOMA; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OBESITY, ABDOMINAL; PROGNOSIS;

EID: 84897379249     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.12.025     Document Type: Article

References (29)

1. M.A. Voss, R. Ganesan, and L. Ludeman et al. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation Gynecol Oncol 124 2012 15 20
2. C.M. Nagle, L. Marquart, and C.J. Bain et al. Impact of weight change and weight cycling on risk of different subtypes of endometrial cancer Eur J Cancer 49 2013 2717 2726
3. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
4. P. Wartko, M.E. Sherman, H.P. Yang, A.S. Felix, L.A. Brinton, and B. Trabert Recent changes in endometrial cancer trends among menopausal-age US women Cancer Epidemiol 37 2013 374 377
5. P. Benedetti Panici, S. Basile, and F. Maneschi et al. Systematic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 100 2008 11707 11716
6. S. Basile, M.G. Salerno, and P. Benedetti Panici Lymphadenectomy in endometrial cancer: what's the right question? Am J Obstet Gynecol 206 2012 3 4
7. H. Kitchener, A.M. Swart, and Q. Qian et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 2009 125 136
8. K. May, A. Bryant, H.O. Dickinson, S. Kehoe, and J. Morrison Lymphadenectomy for the management of endometrial cancer Cochrane Database Syst Rev 20 2010 CD007585
9. N.D. Fleming, S.E. Lentz, I. Cass, A.J. Li, B.Y. Karlan, and C.S. Walsh Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma? Gynecol Oncol 120 2011 189 192
10. A. Ahmed, G. Zamba, K. DeGeest, and C.F. Lynch The impace of surgery on survival of elderly women with endometrial cancer in the SEER program from 1992-2002 Gynecol Oncol 111 2008 35 40
11. S. Jolly, C.E. Vargas, and T. Kumar et al. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation Gynecol Oncol 103 2006 87 93
12. A.J. Mundt, S. Waggoner, K. Yamada, J. Rotmensch, and P.P. Connell Age as a prognostic factor for recurrence in patients with endometrial carcinoma Gynecol Oncol 79 2000 79 85
13. K.M. Alektiar, E. Venkatraman, N. Abu-Rustum, and R. Barakat Is endometrial carcinoma intrinsically more aggressive in elderly patients? Cancer 98 2003 2368 2377
14. P.T. Truong, H.A. Kader, and B. Lacy et al. The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer Am J Clin Oncol 28 2005 157 164
15. V. Bookhman Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 1983 10 17
16. G. Rose Endometrial carcinoma N Engl J Med 335 1996 640 649
17. D. Llobet, J. Pallares, and A. Yeramian et al. Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints J Clin Pathol 62 2009 777 785
18. A. Koul, R. Willén, P.O. Bendahl, M. Nilbert, and Borg Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis Cancer 94 2002 2369 2379
19. M. Koshiyama, I. Konishi, and D.P. Wang et al. Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status Virchows Arch A Pathol Anat Histopathol 423 1993 265 271
20. L. Albitar, G. Pickett, M. Morgan, S. Davies, and K.K. Leslie Models representing type I and type II human endometrial cancers: Ishikawa H and Hec50co cells Gynecol Oncol 106 2007 52 64
21. A.S. Felix, J.L. Weissfeld, and R.A. Stone et al. Factors associated with Type I and Type II endometrial cancer Cancer Causes Control 21 2010 1851 1856
22. H.J. Kim, T.J. Kim, and Y.Y. Lee et al. A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system J Gynecol Oncol 24 2013 120 127
23. C.L. Creutzberg, W.L. van Putten, and P.C. Koper et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411
24. H.M. Keys, J.A. Roberts, and V.L. Brunetto et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 2004 744 751
25. A. Kong, N. Johnson, H.C. Kitchener, and T.A. Lawrie Adjuvant radiotherapy for stage I endometrial cancer Cochrane Database Syst Rev 4 2012 CD003916
26. M.L. McCullough, A.V. Patel, and R. Patel et al. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype Cancer Epidemiol Biomarkers Prev 17 2008 73 79
27. T. Bjørge, A. Engeland, S. Tretli, and E. Weiderpass Body size in relation to cancer of the uterine corpus in 1 million Norwegian women Int J Cancer 120 2007 378 383
28. E.E. Calle, and R. Kaaks Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 2004 579 591
29. C.M. Dallal, L.A. Brinton, and D.C. Bauer et al. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B∼FIT cohort Endocr Relat Cancer 20 2013 151 160